WASHINGTON — The Supreme Court seemed split on Wednesday on whether to allow generic drug makers to be sued in state court for not trying to get federal regulators to add warnings about potentially dangerous side effects to their drug labels.
Business News, Financial News, Business Headlines & Analysis - The Washington Post, Washington Post: Business
Wed, 03/30/2011 - 11:46am
WASHINGTON — The Supreme Court seemed split on Wednesday on whether to allow generic drug makers to be sued in state court for not trying to get federal regulators to add warnings about potentially dangerous side effects to their drug labels.